WO2001096524A3 - Nouveau polypeptide, recepteur humain sigma 10.67, et polynucleotide codant ce polypeptide - Google Patents

Nouveau polypeptide, recepteur humain sigma 10.67, et polynucleotide codant ce polypeptide Download PDF

Info

Publication number
WO2001096524A3
WO2001096524A3 PCT/CN2001/000892 CN0100892W WO0196524A3 WO 2001096524 A3 WO2001096524 A3 WO 2001096524A3 CN 0100892 W CN0100892 W CN 0100892W WO 0196524 A3 WO0196524 A3 WO 0196524A3
Authority
WO
WIPO (PCT)
Prior art keywords
polypeptide
polynucleotide encoding
sigma receptor
novel
human sigma
Prior art date
Application number
PCT/CN2001/000892
Other languages
English (en)
Chinese (zh)
Other versions
WO2001096524A2 (fr
Inventor
Yumin Mao
Yi Xie
Original Assignee
Shanghai Biowindow Gene Dev
Yumin Mao
Yi Xie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Biowindow Gene Dev, Yumin Mao, Yi Xie filed Critical Shanghai Biowindow Gene Dev
Priority to AU89509/01A priority Critical patent/AU8950901A/en
Publication of WO2001096524A2 publication Critical patent/WO2001096524A2/fr
Publication of WO2001096524A3 publication Critical patent/WO2001096524A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Abstract

L'invention concerne un nouveau polypeptide, un récepteur humain sigma 10.67, et un polynucléotide codant ce polypeptide ainsi qu'un procédé d'obtention de ce polypeptide par des techniques recombinantes d'ADN. L'invention concerne en outre les applications de ce polypeptide dans le traitement de maladies. L'invention concerne par ailleurs l'antagoniste agissant contre le polypeptide et son action thérapeutique ainsi que les applications de ce polynucléotide codant le récepteur humain sigma 10.67.
PCT/CN2001/000892 2000-06-05 2001-06-04 Nouveau polypeptide, recepteur humain sigma 10.67, et polynucleotide codant ce polypeptide WO2001096524A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU89509/01A AU8950901A (en) 2000-06-05 2001-06-04 A novel polypeptide, a human sigma receptor 10.67 and the polynucleotide encoding the polypeptide

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN 00116311 CN1326948A (zh) 2000-06-05 2000-06-05 一种新的多肽——人sigma受体10.67和编码这种多肽的多核苷酸
CN00116311.6 2000-06-05

Publications (2)

Publication Number Publication Date
WO2001096524A2 WO2001096524A2 (fr) 2001-12-20
WO2001096524A3 true WO2001096524A3 (fr) 2002-05-02

Family

ID=4585719

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2001/000892 WO2001096524A2 (fr) 2000-06-05 2001-06-04 Nouveau polypeptide, recepteur humain sigma 10.67, et polynucleotide codant ce polypeptide

Country Status (3)

Country Link
CN (1) CN1326948A (fr)
AU (1) AU8950901A (fr)
WO (1) WO2001096524A2 (fr)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5385946A (en) * 1986-07-10 1995-01-31 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon Method for treating hypertension with disubstituted granidine compounds
US5863766A (en) * 1997-09-12 1999-01-26 Incyte Pharmaceuticals, Inc. Human sigma receptor

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5385946A (en) * 1986-07-10 1995-01-31 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon Method for treating hypertension with disubstituted granidine compounds
US5863766A (en) * 1997-09-12 1999-01-26 Incyte Pharmaceuticals, Inc. Human sigma receptor

Also Published As

Publication number Publication date
AU8950901A (en) 2001-12-24
CN1326948A (zh) 2001-12-19
WO2001096524A2 (fr) 2001-12-20

Similar Documents

Publication Publication Date Title
WO2001096524A3 (fr) Nouveau polypeptide, recepteur humain sigma 10.67, et polynucleotide codant ce polypeptide
WO2001096526A3 (fr) Nouveau polypeptide, facteur humain 11.77 d'inhibition tumorale, et polynucleotide codant ce polypeptide
WO2002008421A1 (fr) Nouveau polypeptide, recepteur humain 21.45 du facteur de la necrose tumorale, et polynucleotide codant ce polypeptide
WO2002000826A3 (fr) Nouveau polypeptide, proteine humaine de methylation d'adn, et polynucleotide codant ce polypeptide
WO2002000822A3 (fr) Nouveau polypeptide, sous-unite humaine 2 $g(b) 16.5 du facteur d'initiation necessaire a la synthese proteique, et polynucleotide codant ce polypeptide
WO2002008422A1 (fr) Nouveau polypeptide, proteine du myotube humaine 10.56, et polynucleotide codant ce polypeptide
WO2001075036A3 (fr) Nouveau polypeptide, immunophiline humaine 14, et polynucleotide codant pour ce polypeptide
WO2001075011A3 (fr) Nouveau polypeptide, proteine humaine de constitution 10 de cytochromes, et polynucleotide codant pour ce polypeptide
WO2001075016A3 (fr) Nouveau polypeptide, tyrosinase humaine 16, et polynucleotide codant pour ce polypeptide
WO2002000824A3 (fr) Nouveau polypeptide, proteine humaine 10.56 du gene cancerigene tre, et polynucleotide codant ce polypeptide
WO2002010400A1 (fr) Nouveau polypeptide, arnt-guanine transglycosylase 17.82, et polynucleotide codant ce polypeptide
WO2001083685A3 (fr) Nouveau polypeptide, proteine cap 10, et polynucleotide codant pour ce polypeptide
WO2001094540A3 (fr) Nouveau polypeptide, glycosyl hydrolase humaine 23, et polynucleotide codant ce polypeptide
WO2001075053A3 (fr) Nouveau polypeptide, chaperonine humaine 14, et polynucleotide codant pour ce polypeptide
WO2001075020A3 (fr) Nouveau polypeptide, neuroproteine humaine y 11, et polynucleotide codant pour ce polypeptide
WO2001075043A3 (fr) Nouveau polypeptide, proteine kinase humaine 9 adn-dependante, et polynucleotide codant pour ce polypeptide
WO2001075054A3 (fr) Nouveau polypeptide, facteur humain de regulation 30 de la transcription de la microglobuline, et polynucleotide codant pour ce polypeptide
WO2001079439A3 (fr) Nouveau polypeptide, proteine humaine de reception cannabinoide 19, et un polynucleotide codant pour ce polypeptide
WO2001094533A3 (fr) Nouveau polypeptide, proteine humaine 13 de regulation de la proteine phosphorylase, et polynucleotide codant ce polypeptide
WO2001094531A3 (fr) A novel polypeptide, globuline humaine 12 de l'uterus, et polynucleotide codant ce polypeptide
WO2001075025A3 (fr) Nouveau polypeptide, thyroglobuline humaine 9, et polynucleotide codant pour ce polypeptide
WO2001075010A3 (fr) Nouveau polypeptide, proteine humaine de transduction nucleaire 25 contenant un domaine structurel atp/gtp, et polynucleotide codant pour ce polypeptide
WO2001079431A3 (fr) Nouveau polypeptide, proteine humaine d'interaction 15 avec la proteine huntingtine, et polynucleotide codant pour ce polypeptide
WO2001083682A3 (fr) Nouveau polypeptide, proteine pax humaine 11.6, et polynucleotide codant pour ce polypeptide
WO2001077287A3 (fr) Nouveau polypeptide, globine humaine de l'uterus 11, et polynucleotide codant pour ce polypeptide

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP